Alan Landay to Cervix Uteri
This is a "connection" page, showing publications Alan Landay has written about Cervix Uteri.
Connection Strength
1.327
-
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol. 2007 Sep; 14(9):1102-7.
Score: 0.295
-
Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 2003 Mar 07; 17(4):455-80.
Score: 0.217
-
Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):454-9.
Score: 0.158
-
Characterization of IL-22 and IL-17 Expressing Leukocytes in the Cervix. Am J Reprod Immunol. 2016 Jan; 75(1):42-50.
Score: 0.130
-
T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN. PLoS One. 2015; 10(6):e0130146.
Score: 0.127
-
Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007 Dec 05; 369(1):55-68.
Score: 0.074
-
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004 Dec 01; 190(11):1970-8.
Score: 0.061
-
Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol. 2002 Sep; 161(3):867-73.
Score: 0.052
-
Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. J Infect Dis. 2002 Feb 15; 185(4):439-47.
Score: 0.050
-
The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res. 2000 Aug; 20(8):719-24.
Score: 0.045
-
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol. 1998 Aug; 153(2):481-90.
Score: 0.039
-
Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8.
Score: 0.037
-
HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis. 2004 Aug 01; 190(3):619-23.
Score: 0.015
-
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
Score: 0.013
-
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis. 2001 Nov 01; 184(9):1187-91.
Score: 0.012